Literature DB >> 15951559

Evaluation of vascular signal in pancreatic ductal carcinoma using contrast enhanced ultrasonography: effect of systemic chemotherapy.

A Kobayashi, T Yamaguchi, T Ishihara, H Tadenuma, K Nakamura, H Saisho.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15951559      PMCID： PMC1774618          DOI： 10.1136/gut.2005.065789

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  7 in total

1.  Evaluation of blood flow in pancreatic ductal carcinoma using contrast-enhanced, wide-band Doppler ultrasonography: correlation with tumor characteristics and vascular endothelial growth factor.

Authors:  Tadashi Ohshima; Taketo Yamaguchi; Takeshi Ishihara; Masaharu Yoshikawa; Akitoshi Kobayashi; Nobuyuki Sakaue; Takeshi Baba; Syuji Yamada; Hiromitsu Saisho
Journal:  Pancreas       Date:  2004-04       Impact factor: 3.327

2.  Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography.

Authors:  M Kitano; M Kudo; K Maekawa; Y Suetomi; H Sakamoto; N Fukuta; R Nakaoka; T Kawasaki
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

3.  Contrast-enhanced transabdominal ultrasonography in the diagnosis of pancreatic mass lesions.

Authors:  K Takeda; H Goto; Y Hirooka; A Itoh; S Hashimoto; K Niwa; T Hayakawa
Journal:  Acta Radiol       Date:  2003-01       Impact factor: 1.990

4.  Contrast-enhanced sonography of small pancreatic mass lesions.

Authors:  Yutaka Ozawa; Kazushi Numata; Katsuaki Tanaka; Norio Ueno; Takayoshi Kiba; Koji Hara; Manabu Morimoto; Takashi Sakaguchi; Hisahiko Sekihara; Toru Kubota; Hiroshi Shimada; Yukio Nakatani
Journal:  J Ultrasound Med       Date:  2002-09       Impact factor: 2.153

5.  Evaluation of contrast enhancement patterns in pancreatic tumors by coded harmonic sonographic imaging with a microbubble contrast agent.

Authors:  Michitaka Nagase; Junji Furuse; Hiroshi Ishii; Masahiro Yoshino
Journal:  J Ultrasound Med       Date:  2003-08       Impact factor: 2.153

6.  Predictive value of carbohydrate antigen 19-9 in pancreatic cancer treated with radiochemotherapy.

Authors:  Oliver Micke; Frank Bruns; Rene Kurowski; Eckehard Horst; Alexander F deVries; John W Hausler; Normann Willich; Ulrich Schäfer
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-09-01       Impact factor: 7.038

7.  Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer.

Authors:  U Halm; T Schumann; I Schiefke; H Witzigmann; J Mössner; V Keim
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640
  7 in total
  3 in total

1.  Contrast-enhanced ultrasound of the pancreas.

Authors:  Mirko D'Onofrio; Anna Gallotti; Francesco Principe; Roberto Pozzi Mucelli
Journal:  World J Radiol       Date:  2010-03-28

2.  Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasound.

Authors:  C F Dietrich; B Braden; M Hocke; M Ott; A Ignee
Journal:  J Cancer Res Clin Oncol       Date:  2007-10-19       Impact factor: 4.553

3.  Deep learning radiomics based on contrast-enhanced ultrasound images for assisted diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis.

Authors:  Tong Tong; Jionghui Gu; Dong Xu; Ling Song; Qiyu Zhao; Fang Cheng; Zhiqiang Yuan; Shuyuan Tian; Xin Yang; Jie Tian; Kun Wang; Tian'an Jiang
Journal:  BMC Med       Date:  2022-03-02       Impact factor: 8.775
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.